Grainyhead-like 2 in development and cancer.

Area of Science:

• Developmental Biology
• Cancer Biology
• Molecular Oncology

Background:

• Grainyhead-like 2 (GRHL2) is a key regulator of epithelial-to-mesenchymal transition (EMT).
• GRHL2 plays vital roles in embryonic development, including neural tube closure and epithelial morphogenesis.
• EMT is a critical process shared between embryonic development and cancer progression.

Purpose of the Study:

• To review the dual role of GRHL2 in embryonic development and carcinogenesis.
• To elucidate the regulatory network and mechanisms of GRHL2 in various cancers.
• To reconcile controversial findings regarding GRHL2's function in cancer.

Main Methods:

• Literature review of developmental biology and cancer research.
• Analysis of studies investigating GRHL2's involvement in cell junction protein expression (e.g., E-cadherin, vimentin).
• Synthesis of evidence on GRHL2's oncogenic or tumor-suppressive functions.

Main Results:

• GRHL2 inhibits EMT, essential for cell migration and tissue integrity.
• GRHL2's function in cancer is context-dependent, with conflicting reports on its oncogenic or tumor-suppressive activities.
• Mechanisms underlying GRHL2's contradictory roles in carcinogenesis remain unclear.

Conclusions:

• GRHL2 is a significant factor in both normal development and cancer.
• Further research is needed to fully understand GRHL2's complex regulatory network and its implications in diverse cancer types.
• Clarifying GRHL2's role may offer new therapeutic strategies for cancer treatment.